1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. EIGER BIOPHARMACEUTICALS INC

Eiger BioPharmaceuticals Inc

XNAS: EIGRQ

Watchlist

Portfolio

Share
Board Meeting
The next board meeting for Eiger BioPharmaceuticals Inc is on 15 Apr 2025 for the purpose of Eiger BioPharmaceuticals Inc Annual General Meeting for 2024 See details


Insider Trading disclosures for Eiger BioPharmaceuticals Inc

The latest disclosure was made by David Apelian in Eiger BioPharmaceuticals Inc where a trade of 750,000 Stock Option (Right to Buy) done was reported to US exchanges on July 3, 2023.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
David Apelian Director, CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Jul 2023 750,000 750,000 - - Stock Option (Right to Buy)
James Vollins General Counsel Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Apr 2023 120,000 120,000 - - Stock Option (Right to Buy)
Eldon C. Mayer Ex VP & Chief Commerc. Officer Sale of securities on an exchange or to another person at price $ 1.07 per share. 17 Mar 2023 2,520 57,948 (0%) 0% 1.1 2,696 Common Stock
Eldon C. Mayer Ex VP & Chief Commerc. Officer Sale of securities on an exchange or to another person at price $ 1.07 per share. 17 Mar 2023 1,875 56,073 (0%) 0% 1.1 2,008 Common Stock
Amit K. Sachdev Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Mar 2023 28,000 28,000 - - Stock Option (Right to Buy)
Lisa Kelly-Croswell Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Mar 2023 28,000 28,000 - - Stock Option (Right to Buy)
Thomas J. Dietz Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Mar 2023 40,000 40,000 - - Stock Option (Right to Buy)
Christine Murray Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Mar 2023 28,000 28,000 - - Stock Option (Right to Buy)
Evan Loh Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Mar 2023 28,000 28,000 - - Stock Option (Right to Buy)
Jeffrey S Glenn Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Mar 2023 28,000 28,000 - - Stock Option (Right to Buy)
Eldon C. Mayer Ex VP & Chief Commerc. Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Mar 2023 98,000 98,000 - - Stock Option (Right to Buy)
Kim Sablich Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Mar 2023 28,000 28,000 - - Stock Option (Right to Buy)
David Apelian Director, Interim CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2023 170,000 170,000 - - Stock Option (Right to Buy)
Eldon C. Mayer Ex VP & Chief Commerc. Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jan 2023 31,500 31,500 - - Stock Option (Right to Buy)
Erik Atkisson GC & Chief Compliance Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jan 2023 26,750 26,750 - - Stock Option (Right to Buy)
Thomas J. Dietz Director Purchase of securities on an exchange or from another person at price $ 1.43 per share. 23 Jan 2023 50,000 50,000 (0%) 0% 1.4 71,580 Common Stock
Christine Murray Director Sale of securities on an exchange or to another person at price $ 1.22 per share. 29 Dec 2022 5,000 11,000 (0%) 0% 1.2 6,104 Common Stock
Thomas J. Dietz Director Sale of securities on an exchange or to another person at price $ 1.17 per share. 22 Dec 2022 22,500 21,000 (0%) 0% 1.2 26,303 Common Stock
Jeffrey S Glenn Director Purchase of securities on an exchange or from another person at price $ 1.28 per share. 22 Dec 2022 100,000 182,355 (0%) 0% 1.3 127,950 Common Stock
David Apelian Director Sale of securities on an exchange or to another person at price $ 9.81 per share. 16 Aug 2022 5,000 11,000 (0%) 0% 9.8 49,031 Common Stock
Lisa Kelly-Croswell Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Jul 2022 30,000 30,000 - - Stock Option (Right to Buy)
Eldon C. Mayer Ex VP & Chief Commerc. Officer Sale of securities on an exchange or to another person at price $ 5.60 per share. 14 Mar 2022 1,657 60,468 (0%) 0% 5.6 9,275 Common Stock
Sriram Ryali Chief Financial Officer Sale of securities on an exchange or to another person at price $ 5.60 per share. 14 Mar 2022 2,266 41,566 (0%) 0% 5.6 12,683 Common Stock
Eldon C. Mayer Ex VP & Chief Commerc. Officer Sale of securities on an exchange or to another person at price $ 4.95 per share. 07 Jan 2022 1,560 46,125 (0%) 0% 5.0 7,722 Common Stock
Erik Atkisson GC & Chief Compliance Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Sep 2021 180,000 180,000 - - Stock Option (Right to Buy)
David A. Cory Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Jul 2021 48,750 48,750 - - Stock Option (Right to Buy)
Eldon C. Mayer Ex VP & Chief Commerc. Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Jul 2021 17,500 17,500 - - Stock Option (Right to Buy)
Sriram Ryali Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Jul 2021 30,000 30,000 - - Stock Option (Right to Buy)
Sriram Ryali Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 May 2021 87,000 87,000 - - Stock Option (Right to Buy)
Kim Sablich Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Apr 2021 25,000 25,000 - - Stock Option (right to buy)
Thomas J. Dietz Director Purchase of securities on an exchange or from another person at price $ 8.48 per share. 09 Apr 2021 1,500 36,500 (0%) 0% 8.5 12,720 Common Stock
Thomas J. Dietz Director Purchase of securities on an exchange or from another person at price $ 8.50 per share. 09 Apr 2021 1,000 37,500 (0%) 0% 8.5 8,500 Common Stock
Amit K. Sachdev Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Mar 2021 10,000 10,000 - - Stock Option (Right to Buy)
Amit K. Sachdev Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Mar 2021 5,000 10,000 (0%) 0% 0 Common Stock
James P. Shaffer Chief Business Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Mar 2021 11,875 29,296 (0%) 0% 0 Common Stock
James P. Shaffer Chief Business Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Mar 2021 71,250 71,250 - - Stock Option (Right to Buy)
David A. Cory Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Mar 2021 281,000 281,000 - - Stock Option (Right to Buy)
David A. Cory Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Mar 2021 47,000 117,846 (0%) 0% 0 Common Stock
Thomas J. Dietz Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Mar 2021 20,000 20,000 - - Stock Option (Right to Buy)
Thomas J. Dietz Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Mar 2021 5,000 35,000 (0%) 0% 0 Common Stock
David Apelian Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Mar 2021 5,000 10,000 (0%) 0% 0 Common Stock
David Apelian Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Mar 2021 10,000 10,000 - - Stock Option (Right to Buy)
Christine Murray Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Mar 2021 5,000 10,000 (0%) 0% 0 Common Stock
Christine Murray Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Mar 2021 10,000 10,000 - - Stock Option (Right to Buy)
Evan Loh Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Mar 2021 10,000 10,000 - - Stock Option (Right to Buy)
Evan Loh Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Mar 2021 5,000 10,000 (0%) 0% 0 Common Stock
Evan Loh Director Sale of securities on an exchange or to another person at price $ 10.14 per share. 12 Mar 2021 2,000 8,000 (0%) 0% 10.1 20,280 Common Stock
Jeffrey S Glenn Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Mar 2021 5,000 76,355 (0%) 0% 0 Common Stock
Jeffrey S Glenn Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Mar 2021 10,000 10,000 - - Stock Option (Right to Buy)
Stephana Patton See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Mar 2021 11,875 17,948 (0%) 0% 0 Common Stock
Stephana Patton See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Mar 2021 71,250 71,250 - - Stock Option (Right to Buy)
Eldon C. Mayer Ex VP & Chief Commerc. Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Mar 2021 71,250 71,250 - - Stock Option (Right to Buy)
Eldon C. Mayer Ex VP & Chief Commerc. Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Mar 2021 11,875 47,685 (0%) 0% 0 Common Stock
Sriram Ryali Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Mar 2021 16,250 18,152 (0%) 0% 0 Common Stock
Sriram Ryali Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Mar 2021 97,500 97,500 - - Stock Option (Right to Buy)
Eldon C. Mayer Ex VP & Chief Commerc. Officer Sale of securities on an exchange or to another person at price $ 11.68 per share. 08 Jan 2021 1,690 35,810 (0%) 0% 11.7 19,739 Common Stock
Jeffrey Glenn None Purchase of securities on an exchange or from another person at price $ 11.49 per share. 11 Aug 2020 5,000 71,355 (0%) 0% 11.5 57,464 Common Stock
Jeffrey Glenn None Purchase of securities on an exchange or from another person at price $ 11.28 per share. 11 Aug 2020 500 500 (0%) 0% 11.3 5,638 Common Stock
Jeffrey Glenn None Purchase of securities on an exchange or from another person at price $ 11.44 per share. 11 Aug 2020 4,500 5,000 (0%) 0% 11.4 51,465 Common Stock
Thomas J. Dietz None Purchase of securities on an exchange or from another person at price $ 4.95 per share. 16 Mar 2020 1,000 30,000 (0%) 0% 5.0 4,950 Common Stock
Jeffrey Glenn None Purchase of securities on an exchange or from another person at price $ 5.03 per share. 16 Mar 2020 30,000 66,355 (0%) 0% 5.0 150,813 Common Stock
Amit K. Sachdev None Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Mar 2020 10,000 10,000 - - Stock Option (Right to Buy)
Amit K. Sachdev None Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Mar 2020 5,000 5,000 (0%) 0% 0 Common Stock
James P. Shaffer Chief Business Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Mar 2020 50,000 50,000 - - Stock Option (Right to Buy)
James P. Shaffer Chief Business Officer Grant, award, or other acquisition of securities at price $ 7.31 per share. 12 Mar 2020 1,500 15,921 (0%) 0% 7.3 10,965 Common Stock
David Cory Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Mar 2020 230,000 230,000 - - Stock Option (Right to Buy)
David Cory Director, President and CEO Grant, award, or other acquisition of securities at price $ 7.31 per share. 12 Mar 2020 1,500 69,346 (0%) 0% 7.3 10,965 Common Stock
Thomas J. Dietz None Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Mar 2020 5,000 29,000 (0%) 0% 0 Common Stock
Thomas J. Dietz None Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Mar 2020 20,000 20,000 - - Stock Option (Right to Buy)
David Apelian None Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Mar 2020 5,000 5,000 (0%) 0% 0 Common Stock
David Apelian None Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Mar 2020 10,000 10,000 - - Stock Option (Right to Buy)
Christine Murray None Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Mar 2020 10,000 10,000 - - Stock Option (Right to Buy)
Christine Murray None Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Mar 2020 5,000 5,000 (0%) 0% 0 Common Stock
Evan Loh None Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Mar 2020 5,000 5,000 (0%) 0% 0 Common Stock
Evan Loh None Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Mar 2020 10,000 10,000 - - Stock Option (Right to Buy)
Jeffrey Glenn None Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Mar 2020 10,000 10,000 - - Stock Option (Right to Buy)
Jeffrey Glenn None Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Mar 2020 5,000 36,355 (0%) 0% 0 Common Stock
Stephana Patton See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Mar 2020 65,000 65,000 - - Stock Option (Right to Buy)
Stephana Patton See Remarks Grant, award, or other acquisition of securities at price $ 7.31 per share. 12 Mar 2020 820 4,820 (0%) 0% 7.3 5,994 Common Stock
Sriram Ryali Chief Financial Officer Grant, award, or other acquisition of securities at price $ 7.31 per share. 12 Mar 2020 229 1,628 (0%) 0% 7.3 1,674 Common Stock
Sriram Ryali Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Mar 2020 65,000 65,000 - - Stock Option (Right to Buy)
Eldon C. Mayer Ex VP & Chief Commerc. Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2020 7,500 37,500 (0%) 0% 0 Common Stock
Eldon C. Mayer Ex VP & Chief Commerc. Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2020 150,000 150,000 - - Stock Option ( Right to Buy)
Eldon C. Mayer Ex VP & Chief Commerc. Officer Purchase of securities on an exchange or from another person at price $ 13.52 per share. 24 Jan 2020 5,000 30,000 (0%) 0% 13.5 67,603 Common Stock
Thomas J. Dietz None Purchase of securities on an exchange or from another person at price $ 13.94 per share. 10 Jan 2020 4,000 24,000 (0%) 0% 13.9 55,760 Common Stock
James P. Shaffer Chief Business Officer Grant, award, or other acquisition of securities at price $ 7.95 per share. 05 Sep 2019 1,500 14,421 (0%) 0% 7.9 11,921 Common Stock
David Cory Director, President and CEO Grant, award, or other acquisition of securities at price $ 7.95 per share. 05 Sep 2019 1,500 67,846 (0%) 0% 7.9 11,921 Common Stock
Sriram Ryali Chief Financial Officer Grant, award, or other acquisition of securities at price $ 9.37 per share. 05 Sep 2019 149 1,399 (0%) 0% 9.4 1,396 Common Stock
Amit K. Sachdev None Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 May 2019 25,000 25,000 - - Stock Option ( Right to Buy)
David Cory Director, President and CEO Purchase of securities on an exchange or from another person at price $ 11.26 per share. 25 Apr 2019 343 66,346 (0%) 0% 11.3 3,862 Common Stock
Thomas J. Dietz None Purchase of securities on an exchange or from another person at price $ 11.10 per share. 23 Apr 2019 5,000 20,000 (0%) 0% 11.1 55,495 Common Stock
Thomas J. Dietz None Purchase of securities on an exchange or from another person at price $ 11.05 per share. 22 Apr 2019 5,000 15,000 (0%) 0% 11.1 55,250 Common Stock
Stephana Patton See Remarks Purchase of securities on an exchange or from another person at price $ 11.03 per share. 22 Apr 2019 1,000 4,000 (0%) 0% 11.0 11,030 Common Stock
Sriram Ryali Chief Financial Officer Purchase of securities on an exchange or from another person at price $ 11.08 per share. 22 Apr 2019 1,250 1,250 (0%) 0% 11.1 13,853 Common Stock
James P. Shaffer Chief Business Officer Grant, award, or other acquisition of securities at price $ 8.20 per share. 21 Mar 2019 1,301 6,921 (0%) 0% 8.2 10,671 Common Stock
James P. Shaffer Chief Business Officer Grant, award, or other acquisition of securities at price $ 9.90 per share. 21 Mar 2019 1,500 8,421 (0%) 0% 9.9 14,854 Common Stock
James P. Shaffer Chief Business Officer Grant, award, or other acquisition of securities at price $ 8.03 per share. 21 Mar 2019 1,500 9,921 (0%) 0% 8.0 12,049 Common Stock
James P. Shaffer Chief Business Officer Grant, award, or other acquisition of securities at price $ 7.95 per share. 21 Mar 2019 1,500 11,421 (0%) 0% 7.9 11,921 Common Stock
James P. Shaffer Chief Business Officer Grant, award, or other acquisition of securities at price $ 7.95 per share. 21 Mar 2019 1,500 12,921 (0%) 0% 7.9 11,921 Common Stock
James P. Shaffer Chief Business Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Mar 2019 50,000 50,000 - - Stock Option ( Right to Buy)
David Cory Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Mar 2019 200,000 200,000 - - Stock Option ( Right to Buy)
David Cory Director, President and CEO Grant, award, or other acquisition of securities at price $ 8.20 per share. 21 Mar 2019 1,325 60,003 (0%) 0% 8.2 10,868 Common Stock
David Cory Director, President and CEO Grant, award, or other acquisition of securities at price $ 9.90 per share. 21 Mar 2019 1,500 61,503 (0%) 0% 9.9 14,854 Common Stock
David Cory Director, President and CEO Grant, award, or other acquisition of securities at price $ 8.03 per share. 21 Mar 2019 1,500 63,003 (0%) 0% 8.0 12,049 Common Stock
David Cory Director, President and CEO Grant, award, or other acquisition of securities at price $ 7.95 per share. 21 Mar 2019 1,500 64,503 (0%) 0% 7.9 11,921 Common Stock
David Cory Director, President and CEO Grant, award, or other acquisition of securities at price $ 7.95 per share. 21 Mar 2019 1,500 66,003 (0%) 0% 7.9 11,921 Common Stock
Thomas J. Dietz None Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Mar 2019 20,000 20,000 - - Stock Option ( Right to Buy)
David Apelian Director, COO and Ex. Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Mar 2019 110,500 110,500 - - Stock Option ( Right to Buy)
Christine Murray None Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Mar 2019 10,000 10,000 - - Stock Option ( Right to Buy)
Evan Loh None Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Mar 2019 10,000 10,000 - - Stock Option ( Right to Buy)
Jeffrey Glenn None Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Mar 2019 10,000 10,000 - - Stock Option ( Right to Buy)
Stephana Patton See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Mar 2019 90,000 90,000 - - Stock Option ( Right to Buy)
Eldon C. Mayer None Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Mar 2019 10,000 10,000 - - Stock Option ( Right to Buy)
David Cory Director, President and CEO Purchase of securities on an exchange or from another person at price $ 14.13 per share. 04 Feb 2019 227 58,678 (0%) 0% 14.1 3,208 Common Stock
Christine Murray None Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jan 2019 25,000 25,000 - - Stock Option ( Right to Buy)
Sriram Ryali Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Jan 2019 90,000 90,000 - - Stock Option ( Right to Buy)
Thomas J. Dietz None Purchase of securities on an exchange or from another person at price $ 9.98 per share. 20 Dec 2018 5,000 10,000 (0%) 0% 10.0 49,900 Common Stock
Thomas J. Dietz None Purchase of securities on an exchange or from another person at price $ 11.26 per share. 06 Dec 2018 5,000 5,000 (0%) 0% 11.3 56,300 Common Stock
Eldon C. Mayer None Purchase of securities on an exchange or from another person at price $ 10.21 per share. 29 Nov 2018 4,000 25,000 (0%) 0% 10.2 40,840 Common Stock
Eldon C. Mayer None Purchase of securities on an exchange or from another person at price $ 10.07 per share. 26 Nov 2018 6,000 21,000 (0%) 0% 10.1 60,447 Common Stock
Eldon C. Mayer None Purchase of securities on an exchange or from another person at price $ 9.75 per share. 26 Nov 2018 7,500 7,500 (0%) 0% 9.8 73,143 Common Stock
Eldon C. Mayer None Purchase of securities on an exchange or from another person at price $ 9.92 per share. 26 Nov 2018 7,500 15,000 (0%) 0% 9.9 74,408 Common Stock
Joanne Quan Chief Medical Officer Sale of securities on an exchange or to another person at price $ 10.00 per share. 02 Apr 2018 4,000 0 (0%) 0% 10 40,000 Common Stock
Joanne Quan Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.06 per share. 02 Apr 2018 4,000 4,000 (0%) 0% 2.1 8,240 Common Stock
Joanne Quan Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 02 Apr 2018 4,000 22,256 - - Stock Option (Right to Buy)
James P. Shaffer Chief Business Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Mar 2018 60,000 60,000 - - Stock Option (Right to Buy)
James H. Welch Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Mar 2018 60,000 60,000 - - Stock Option (Right to Buy)
David Cory Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Mar 2018 190,000 190,000 - - Stock Option (Right to Buy)
Thomas J. Dietz None Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Mar 2018 10,000 10,000 - - Stock Option (Right to Buy)
David Apelian Director, COO and Ex. Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Mar 2018 37,000 37,000 - - Stock Option (Right to Buy)
Evan Loh None Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Mar 2018 10,000 10,000 - - Stock Option (Right to Buy)
Joanne Quan Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Mar 2018 60,000 60,000 - - Stock Option (Right to Buy)
Jeffrey Glenn None Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Mar 2018 10,000 10,000 - - Stock Option (Right to Buy)
Eldon C. Mayer None Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Mar 2018 10,000 10,000 - - Stock Option (Right to Buy)
David Apelian Director, COO and Ex. Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Jan 2018 150,000 150,000 - - Stock Option (Right to Buy)
Eldon C. Mayer None Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Jan 2018 25,000 25,000 - - Stock Option (right to buy)
David Apelian None Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Sep 2017 25,000 25,000 - - Stock Option (Right to Buy)
Evan Loh None Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Sep 2017 25,000 25,000 - - Stock Option (Right to Buy)
Jeffrey Glenn None Purchase of securities on an exchange or from another person at price $ 9.53 per share. 01 Sep 2017 15,000 31,355 (0%) 0% 9.5 142,950 Common Stock
Charles J. Bramlage None Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Apr 2017 10,000 10,000 - - Stock Option (Right to Buy)
Edgar G. Engleman Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Apr 2017 10,000 10,000 - - Stock Option (Right to Buy)
Nina Kjellson None Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Apr 2017 10,000 10,000 - - Stock Option (Right to Buy)
Thomas J. Dietz None Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Apr 2017 10,000 10,000 - - Stock Option (Right to Buy)
Jeffrey Glenn None Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Apr 2017 10,000 10,000 - - Stock Option (Right to Buy)
James H. Welch Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Mar 2017 40,000 40,000 - - Stock Option (Right to Buy)
James P. Shaffer Chief Business Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Mar 2017 40,000 40,000 - - Stock Option (Right to Buy)
David Cory Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Mar 2017 133,000 133,000 - - Stock Option (Right to Buy)
Joanne Quan Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Mar 2017 30,000 30,000 - - Stock Option (Right to Buy)
Eduardo Martins SVP, Liver and Infectious Dise Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Mar 2017 30,000 30,000 - - Stock Option (Right to Buy)
Jeffrey Glenn None Purchase of securities on an exchange or from another person at price $ 0.00 per share. 17 Nov 2016 460 460 - - Common Stock
Jeffrey Glenn None Purchase of securities on an exchange or from another person at price $ 0.00 per share. 17 Nov 2016 15,000 16,355 - - Common Stock
David Cory Director, President and CEO Purchase of securities on an exchange or from another person at price $ 0.00 per share. 18 Aug 2016 1,562 58,451 - - Common Stock
James P. Shaffer Chief Business Officer Purchase of securities on an exchange or from another person at price $ 0.00 per share. 18 Aug 2016 3,125 5,620 - - Common Stock
James H. Welch Chief Financial Officer Purchase of securities on an exchange or from another person at price $ 0.00 per share. 20 Jun 2016 500 2,500 - - Common Stock
James H. Welch Chief Financial Officer Purchase of securities on an exchange or from another person at price $ 0.00 per share. 20 Jun 2016 2,000 2,000 - - Common Stock
James P. Shaffer Chief Business Officer Purchase of securities on an exchange or from another person at price $ 0.00 per share. 13 Jun 2016 420 2,495 - - Common Stock
James P. Shaffer Chief Business Officer Purchase of securities on an exchange or from another person at price $ 0.00 per share. 13 Jun 2016 100 2,075 - - Common Stock
James P. Shaffer Chief Business Officer Purchase of securities on an exchange or from another person at price $ 0.00 per share. 13 Jun 2016 730 1,975 - - Common Stock
James P. Shaffer Chief Business Officer Purchase of securities on an exchange or from another person at price $ 0.00 per share. 19 May 2016 745 1,245 - - Common Stock
James P. Shaffer Chief Business Officer Purchase of securities on an exchange or from another person at price $ 0.00 per share. 19 May 2016 500 500 - - Common Stock
Edgar G. Engleman Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Mar 2016 25,000 25,000 - - Stock Option (Right to Buy)
Charles J. Bramlage None Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Mar 2016 25,000 25,000 - - Stock Option (Right to Buy)
Nina Kjellson Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Mar 2016 25,000 25,000 - - Stock Option (Right to Buy)
Thomas J. Dietz None Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Mar 2016 25,000 25,000 - - Stock Option (Right to Buy)
Thomas J. Dietz None Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Mar 2016 23,000 23,000 - - Stock Option (Right to Buy)
Jeffrey Glenn None Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Mar 2016 30,000 30,000 - - Stock Option (Right to Buy)
Jeffrey Glenn None Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Mar 2016 25,000 25,000 - - Stock Option (Right to Buy)
David Cory Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Mar 2016 285,991 285,991 - - Stock Option (Right to Buy)
James H. Welch Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Mar 2016 57,571 57,571 - - Stock Option (Right to Buy)
James P. Shaffer Chief Business Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Mar 2016 60,699 60,699 - - Stock Option (Right to Buy)
Joanne Quan Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Mar 2016 53,452 53,452 - - Stock Option (Right to Buy)
Eduardo Martins SVP, Liver and Infectious Dise Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Mar 2016 65,216 65,216 - - Stock Option (Right to Buy)
Michael A. Narachi None Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jun 2015 10,000 50,000 - - Stock option (right to buy)
Gregg H. Alton None Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jun 2015 10,000 40,000 - - Stock option (right to buy)
Graham K. Cooper None Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jun 2015 10,000 40,000 - - Stock option (right to buy)
Peter K. Honig None Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jun 2015 10,000 22,800 - - Stock option (right to buy)
Krisztina M. Zsebo Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 06 Apr 2015 41,302 652,346 - - Stock option (right to buy)
Krisztina M. Zsebo Director, Chief Executive Officer Sale of securities on an exchange or to another person at price $ 0.00 per share. 06 Apr 2015 6,629 3,125 - - Common Stock
Krisztina M. Zsebo Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 06 Apr 2015 6,629 51,056 - - Common Stock
Krisztina M. Zsebo Director, Chief Executive Officer Sale of securities on an exchange or to another person at price $ 0.00 per share. 06 Apr 2015 41,302 9,754 - - Common Stock
Krisztina M. Zsebo Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 06 Apr 2015 41,302 44,427 - - Common Stock
Krisztina M. Zsebo Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 06 Apr 2015 6,629 645,717 - - Stock option (right to buy)
Rebecque J. Laba VP, Corporate Operations Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 02 Apr 2015 1,012 150,726 - - Stock option (right to buy)
Rebecque J. Laba VP, Corporate Operations Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 02 Apr 2015 10,000 151,738 - - Stock option (right to buy)
Rebecque J. Laba VP, Corporate Operations Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 02 Apr 2015 1,012 13,907 - - Common Stock
Rebecque J. Laba VP, Corporate Operations Sale of securities on an exchange or to another person at price $ 0.00 per share. 02 Apr 2015 10,000 3,907 - - Common Stock
Rebecque J. Laba VP, Corporate Operations Sale of securities on an exchange or to another person at price $ 0.00 per share. 02 Apr 2015 1,012 2,895 - - Common Stock
Rebecque J. Laba VP, Corporate Operations Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 02 Apr 2015 10,000 12,895 - - Common Stock
Ryan K. Takeya VP, Manufacturing Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Apr 2015 4,444 139,574 - - Stock option (right to buy)
Ryan K. Takeya VP, Manufacturing Sale of securities on an exchange or to another person at price $ 0.00 per share. 01 Apr 2015 4,444 1,432 - - Common Stock
Ryan K. Takeya VP, Manufacturing Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Apr 2015 4,444 5,876 - - Common Stock
Krisztina M. Zsebo Director, Chief Executive Officer Sale of securities on an exchange or to another person at price $ 0.00 per share. 09 Mar 2015 6,629 3,125 - - Common Stock
Krisztina M. Zsebo Director, Chief Executive Officer Sale of securities on an exchange or to another person at price $ 0.00 per share. 09 Mar 2015 41,302 9,754 - - Common Stock
Krisztina M. Zsebo Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 09 Mar 2015 6,629 51,056 - - Common Stock
Krisztina M. Zsebo Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 09 Mar 2015 41,302 700,277 - - Stock option (right to buy)
Krisztina M. Zsebo Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 09 Mar 2015 6,629 693,648 - - Stock option (right to buy)
Krisztina M. Zsebo Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 09 Mar 2015 41,302 44,427 - - Common Stock
Rebecque J. Laba VP, Corporate Operations Sale of securities on an exchange or to another person at price $ 0.00 per share. 06 Mar 2015 4,000 2,895 - - Common Stock
Rebecque J. Laba VP, Corporate Operations Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 06 Mar 2015 10,000 12,895 - - Common Stock
Rebecque J. Laba VP, Corporate Operations Sale of securities on an exchange or to another person at price $ 0.00 per share. 06 Mar 2015 10,000 6,895 - - Common Stock
Rebecque J. Laba VP, Corporate Operations Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 06 Mar 2015 10,000 165,738 - - Stock option (right to buy)
Rebecque J. Laba VP, Corporate Operations Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 06 Mar 2015 4,000 161,738 - - Stock option (right to buy)
Rebecque J. Laba VP, Corporate Operations Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 06 Mar 2015 4,000 16,895 - - Common Stock
Peter K. Honig None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 05 Mar 2015 5,000 12,800 - - Stock option (right to buy)
Peter K. Honig None Sale of securities on an exchange or to another person at price $ 0.00 per share. 05 Mar 2015 2,500 2,200 - - Common Stock
Peter K. Honig None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 05 Mar 2015 2,500 20,000 - - Stock option (right to buy)
Peter K. Honig None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 05 Mar 2015 2,500 2,500 - - Common Stock
Peter K. Honig None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 05 Mar 2015 2,200 17,800 - - Stock option (right to buy)
Peter K. Honig None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 05 Mar 2015 2,200 4,700 - - Common Stock
Peter K. Honig None Sale of securities on an exchange or to another person at price $ 0.00 per share. 05 Mar 2015 2,200 0 - - Common Stock
Peter K. Honig None Sale of securities on an exchange or to another person at price $ 0.00 per share. 05 Mar 2015 5,000 0 - - Common Stock
Peter K. Honig None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 05 Mar 2015 5,000 5,000 - - Common Stock
Ryan K. Takeya VP, Manufacturing Sale of securities on an exchange or to another person at price $ 0.00 per share. 02 Mar 2015 7,777 1,432 - - Common Stock
Ryan K. Takeya VP, Manufacturing Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 02 Mar 2015 7,777 9,209 - - Common Stock
Ryan K. Takeya VP, Manufacturing Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 02 Mar 2015 7,777 144,018 - - Stock option (right to buy)
Krisztina M. Zsebo Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 09 Feb 2015 6,629 51,056 - - Common Stock
Krisztina M. Zsebo Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 09 Feb 2015 41,302 44,427 - - Common Stock
Krisztina M. Zsebo Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 09 Feb 2015 6,629 741,579 - - Stock option (right to buy)
Krisztina M. Zsebo Director, Chief Executive Officer Sale of securities on an exchange or to another person at price $ 0.00 per share. 09 Feb 2015 41,302 9,754 - - Common Stock
Krisztina M. Zsebo Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 09 Feb 2015 41,302 748,208 - - Stock option (right to buy)
Krisztina M. Zsebo Director, Chief Executive Officer Sale of securities on an exchange or to another person at price $ 0.00 per share. 09 Feb 2015 6,629 3,125 - - Common Stock
Rebecque J. Laba VP, Corporate Operations Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 06 Feb 2015 10,000 179,738 - - Stock option (right to buy)
Rebecque J. Laba VP, Corporate Operations Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 06 Feb 2015 4,000 16,895 - - Common Stock
Rebecque J. Laba VP, Corporate Operations Sale of securities on an exchange or to another person at price $ 0.00 per share. 06 Feb 2015 4,000 2,895 - - Common Stock
Rebecque J. Laba VP, Corporate Operations Sale of securities on an exchange or to another person at price $ 0.00 per share. 06 Feb 2015 10,000 6,895 - - Common Stock
Rebecque J. Laba VP, Corporate Operations Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 06 Feb 2015 10,000 12,895 - - Common Stock
Rebecque J. Laba VP, Corporate Operations Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 06 Feb 2015 4,000 175,738 - - Stock option (right to buy)
Ryan K. Takeya VP, Manufacturing Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 02 Feb 2015 7,777 9,209 - - Common Stock
Ryan K. Takeya VP, Manufacturing Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 02 Feb 2015 7,777 151,795 - - Stock option (right to buy)
Ryan K. Takeya VP, Manufacturing Sale of securities on an exchange or to another person at price $ 0.00 per share. 02 Feb 2015 7,777 1,432 - - Common Stock
Jeffrey J. Rudy VP, Clinical Operations Sale of securities on an exchange or to another person at price $ 0.00 per share. 09 Jan 2015 10,000 1,024 - - Common Stock
Jeffrey J. Rudy VP, Clinical Operations Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 09 Jan 2015 10,000 181,738 - - Stock option (right to buy)
Jeffrey J. Rudy VP, Clinical Operations Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 09 Jan 2015 10,000 11,024 - - Common Stock
Rebecque J. Laba VP, Corporate Operations Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 07 Jan 2015 20,000 189,738 - - Stock option (right to buy)
Rebecque J. Laba VP, Corporate Operations Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 07 Jan 2015 20,000 22,895 - - Common Stock
Rebecque J. Laba VP, Corporate Operations Sale of securities on an exchange or to another person at price $ 0.00 per share. 07 Jan 2015 20,000 2,895 - - Common Stock
Krisztina M. Zsebo Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 06 Jan 2015 41,302 44,427 - - Common Stock
Krisztina M. Zsebo Director, Chief Executive Officer Sale of securities on an exchange or to another person at price $ 0.00 per share. 06 Jan 2015 41,302 3,125 - - Common Stock
Krisztina M. Zsebo Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 06 Jan 2015 41,302 789,510 - - Stock option (right to buy)
Elizabeth E. Reed VP, General Counsel Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jan 2015 72,000 142,500 - - Stock option (right to buy)
Paul B. Cleveland President and CFO Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jan 2015 140,000 417,500 - - Stock option (right to buy)
Krisztina M. Zsebo Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jan 2015 275,000 830,812 - - Stock option (right to buy)
Rebecque J. Laba VP, Finance and Administration Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jan 2015 80,000 209,738 - - Stock option (right to buy)
Jeffrey J. Rudy VP, Clinical Operations Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jan 2015 80,000 191,738 - - Stock option (right to buy)
Ryan K. Takeya VP, Manufacturing Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Jan 2015 7,777 159,572 - - Stock option (right to buy)
Ryan K. Takeya VP, Manufacturing Sale of securities on an exchange or to another person at price $ 0.00 per share. 01 Jan 2015 7,777 1,432 - - Common Stock
Ryan K. Takeya VP, Manufacturing Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jan 2015 72,000 167,349 - - Stock option (right to buy)
Ryan K. Takeya VP, Manufacturing Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Jan 2015 7,777 9,209 - - Common Stock
Fredrik Wiklund See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jan 2015 80,000 193,243 - - Stock option (right to buy)
Krisztina M. Zsebo Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 09 Dec 2014 41,302 555,812 - - Stock option (right to buy)
Krisztina M. Zsebo Director, Chief Executive Officer Sale of securities on an exchange or to another person at price $ 0.00 per share. 09 Dec 2014 41,302 1,531 - - Common Stock
Krisztina M. Zsebo Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 09 Dec 2014 41,302 42,833 - - Common Stock
Jeffrey J. Rudy VP, Clinical Operations Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 09 Dec 2014 10,000 10,414 - - Common Stock
Jeffrey J. Rudy VP, Clinical Operations Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 09 Dec 2014 10,000 111,738 - - Stock option (right to buy)
Jeffrey J. Rudy VP, Clinical Operations Sale of securities on an exchange or to another person at price $ 0.00 per share. 09 Dec 2014 10,000 414 - - Common Stock
Rebecque J. Laba VP, Finance and Administration Sale of securities on an exchange or to another person at price $ 0.00 per share. 05 Dec 2014 20,000 691 - - Common Stock
Rebecque J. Laba VP, Finance and Administration Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 05 Dec 2014 20,000 129,738 - - Stock option (right to buy)
Rebecque J. Laba VP, Finance and Administration Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 05 Dec 2014 20,000 20,691 - - Common Stock
Ryan K. Takeya VP, Manufacturing Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Dec 2014 7,777 8,354 - - Common Stock
Ryan K. Takeya VP, Manufacturing Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Dec 2014 7,777 95,349 - - Stock option (right to buy)
Ryan K. Takeya VP, Manufacturing Sale of securities on an exchange or to another person at price $ 0.00 per share. 01 Dec 2014 7,777 577 - - Common Stock
Jeffrey J. Rudy VP, Clinical Operations Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 14 Nov 2014 18,000 18,000 - - Common Stock
Jeffrey J. Rudy VP, Clinical Operations Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 14 Nov 2014 18,000 121,738 - - Stock option (right to buy)
Jeffrey J. Rudy VP, Clinical Operations Sale of securities on an exchange or to another person at price $ 0.00 per share. 14 Nov 2014 18,000 0 - - Common Stock
Paul B. Cleveland President and CFO Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Jun 2014 277,500 277,500 - - Stock option (right to buy)
Elizabeth E. Reed VP, General Counsel Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Jun 2014 65,000 65,000 - - Stock option (right to buy)
Fredrik Wiklund See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 May 2014 10,000 10,000 - - Stock option (right to buy)
Michael A. Narachi None Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 May 2014 10,000 10,000 - - Stock option (right to buy)
Gregg H. Alton None Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 May 2014 10,000 10,000 - - Stock option (right to buy)
Graham K. Cooper None Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 May 2014 10,000 10,000 - - Stock option (right to buy)
Peter K. Honig None Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 May 2014 10,000 10,000 - - Stock option (right to buy)
Joshua Funder None Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 May 2014 10,000 10,000 - - Stock option (right to buy)
Patrick Y. Yang None Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 May 2014 10,000 10,000 - - Stock option (right to buy)
Rebecque J. Laba VP Finance & Administration Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Mar 2014 10,000 10,000 - - Stock Option (Right to Buy)
Peter K. Honig None Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Mar 2014 2,500 2,500 - - Stock option (right to buy)
Peter K. Honig None Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Mar 2014 10,000 10,000 - - Stock option (right to buy)
Patrick Y. Yang None Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Mar 2014 2,500 2,500 - - Stock option (right to buy)
Patrick Y. Yang None Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Mar 2014 10,000 10,000 - - Stock option (right to buy)
Michael A. Narachi None Purchase of securities on an exchange or from another person at price $ 0.00 per share. 04 Feb 2014 62,500 62,500 - - Common Stock
Todd A. Foley None 04 Feb 2014 218,806 0 - - Warrant to Purchase Series A-1 Preferred Stock-Right to Buy
Todd A. Foley None 04 Feb 2014 11,788,047 0 - - Series A-1 Convertible Preferred Stock
Todd A. Foley None 04 Feb 2014 11,370 955,167 - - Common Stock
Todd A. Foley None Purchase of securities on an exchange or from another person at price $ 0.00 per share. 04 Feb 2014 111,608 1,066,775 - - Common Stock
Todd A. Foley None 04 Feb 2014 943,797 943,797 - - Common Stock
Todd A. Foley None 04 Feb 2014 17,517 17,517 - - Warrant to Purchase Common Stock-Right to Buy
Todd A. Foley None 04 Feb 2014 11,370 0 - - Convertible Promissory Notes
Joshua Funder None 04 Feb 2014 23,145 966,943 - - Common Stock
Joshua Funder None 04 Feb 2014 23,145 0 - - Convertible Promissory Notes
Joshua Funder None 04 Feb 2014 672,060 0 - - Series A-1 Preferred Warrants
Joshua Funder None Purchase of securities on an exchange or from another person at price $ 0.00 per share. 04 Feb 2014 227,261 1,194,204 - - Common Stock
Joshua Funder None 04 Feb 2014 943,798 943,798 - - Common Stock
Joshua Funder None 04 Feb 2014 53,807 53,807 - - Common Warrants
Joshua Funder None 04 Feb 2014 11,788,047 0 - - Series A-1 Convertible Preferred Stock
Johan Kordel None 04 Feb 2014 18,605 0 - - Convertible Promissory Notes
Johan Kordel None 04 Feb 2014 1,544,397 1,544,397 - - Common Stock
Johan Kordel None 04 Feb 2014 358,049 0 - - Series A-1 Preferred Warrants
Johan Kordel None 04 Feb 2014 19,289,531 0 - - Series A-1 Convertible Preferred Stock
Johan Kordel None 04 Feb 2014 28,666 28,666 - - Common Warrants
Johan Kordel None 04 Feb 2014 18,605 1,563,002 - - Common Stock
Johan Kordel None Purchase of securities on an exchange or from another person at price $ 0.00 per share. 04 Feb 2014 182,681 1,745,683 - - Common Stock
Fredrik Wiklund VP Corp Dvlpmnt & Invs Rltns Purchase of securities on an exchange or from another person at price $ 0.00 per share. 04 Feb 2014 20,000 20,000 - - Common Stock
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures
Screeners based on Insider Trading and SAST parameters